Free radicals and anticancer drug resistance: Oxygen free radicals in the mechanisms of drug cytotoxicity and resistance by certain tumors

Free Radical Biology and Medicine

Volumn 8, Issue 6, 1990, Pages 567-581

  Sinha, Birandra K ^a   Mimnaugh, Edward G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antioxidant enzymes; Glutathione peroxidase; Multi drug resistance; Oxyradicals; Quinone containing anticancer drugs; Resistance; Tumor cells

Indexed keywords

DOXORUBICIN; FREE RADICAL; MITOMYCIN C;

CYTOTOXICITY; DRUG RESISTANCE; DRUG STRUCTURE; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; THEORETICAL STUDY; TUMOR;

ANIMAL; ANTINEOPLASTIC AGENTS; DOXORUBICIN; DRUG RESISTANCE; FREE RADICALS; HUMAN; MITOMYCIN; MITOMYCINS; NEOPLASMS; OXYGEN;

EID: 0025309794     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/0891-5849(90)90155-C     Document Type: Article

References (93)

1. A surface glycoprotein modulating drug permeabiality in Chinese hamster ovary cell mutants
2. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
3. In vivo resistance towards anthracyclines, etoposide, and diamino-dicholroplatinum (I)
4. Topoisomerase alternations associated with drug resistance in a line of Chinese hamster cells
5. Resistance to multiple chemotherapeutic agents in human cancer cells
6. Isolation and characterization of an anthracycline-resistant human leukemic cell line
7. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA
8. MDR1 gene expression in lung cancer
9. Multidrug resistance in mitoxantrone-selected HL-60 leukemia cells in the absence of P-glycoprotein overexpression
10. Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to vinca alkaloids independent of P-glycoprotein
11. Molecular mechanism of action of anticancer agents involving free radical intermediates
12. Free radicals in anticancer drug pharmacology
13. Interactions of some daunomycin derivatives with deoxyribonucleic acids and their biological activities
14. Adriamycin (NSC 123127): mode and mechanism of action
15. Binding specificity of chemically and enzymatically activated anthracyclines anticancer agents to nucleic acids
16. Role of one-electron and two-electron reduction products of adriamycin and daunomycin in DNA binding
17. Enzymatic activation and binding of adriamycin to nuclear DNA
18. Stimulation by adriamycin of heart and liver microsomal NADPH-dependent lipid peroxidation
19. Adriamycin-enhanced lipid peroxidation in isolated rat nuclei
20. A general mechanism for microsomal activation of quinone anticancer agents to free radicals
21. Nuclear catalyzed antibiotic free radical formation
22. Relationship of adriamycin concentrations to DNA lesions induced in hypoxic and euoxic L1210 cells
23. Spin-trapping and direct electron spin resonance investigation of the redox metabolism quinone anticancer drugs
24. An electron spin resonance study of the reduction of peroxide by anthracycline semiquinones
25. One-electron reduction of daunomycin daunomycinone and 7-deoxydaunomycinone by xanthine/xanthine oxidase system detection of semiquinone free radicals by electron spin resonance
26. Further studies on the generation of reactive oxygen species from activated anthracyclines and the relationship to cytotoxic action and cardiotoxic effects
27. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by the anticancer quinones
28. Strand scission of DNA by adriamycin and daunorubicin in the presence of reducing agents
29. Reduction of adriamycin to a semiquinone free radical by NADPH-cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen
30. Enhancement of reactive oxygen-dependent mitochondrial membrane lipid peroxidation by the anticancer drug adriamycin
31. Cytotoxicity of adriamycin on aerobic and hypoxic Chinese hamster V79 cells in vitro
32. Classification of antineoplastic agents by their selective toxicities towards oxygenated and hypoxic tumor cells
33. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich cells
34. Electron spin resonance studies on the mode of generation of free radicals of daunomycin, adriamycin, and carboquinone of free radicals of daunomycin, adriamycin, and carboquinone on NADPH-microsomal system
35. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents
36. Effects of vitamines on lipid peroxidation and suppression of DNA synthesis induced by adriamycin in Ehrlich cells
37. The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells
38. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells
39. Protection against oxygen radicals in biological systems; the superoxide theory of oxygen toxicity
40. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells
41. Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats
42. Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells
43. Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells
44. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cell: implications for the mechanism of action
45. Adriamycin activation and oxygen free radical formation in human breast tumor cells: protective role of glutathione peroxidase in adriamycin resistance
46. Comparative study of the enzymatic defense system against oxygen-derived free radicals: the key role of glutathione peroxidase
47. Differential oxygen radical susceptibility of adriamycin-sensitive and-resistant MCF-7 human breast tumor cells
48. Clinical pharmacokinetics of doxorubicin
49. Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells
50. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells
51. Resistance of paraquat and adriamycin in human breast tumor cells: role of free radical formation
52. Superoxide and singlet oxygen catalyzed lipid peroxidation as a possible mechanism of paraquat (methyl viologen) toxicity
53. 2 inhibition of nitroreductase
54. Resistance to paraquat in a mammalian cell line
55. Regulatory role of glutathione and soluble sulfhydryl-groups in the toxicity of doxorubicin
56. Protective role of glutathione redox cycle against adriamycin-mediated toxicity in isolated hepatocytes
57. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximide mediated glutathione depletion
58. Gltathione as a determinant of cellular response to doxorubicin
59. Glutathione depletion sensitizes tumor cells to oxidative cytolysis
60. Potentiation and protection of doxorubicin cytotoxicity by cellular glutathione modulation
61. Differential cytotoxicity of daunomycin in tumor cells is related to glutathione-dependent hydrogen peroxide metabolism
62. Role of glutathione redox cycle in acquired and de novo multidrug resistance
63. Photoaffinity labeling of the multidrug resistance-related P-glycoprotein with photoactive analogs of verapaminl
64. Role of free radicals in an adriamycin-resistant human small cell lung cancer cell line
65. Resistance mechanism in three human small cell lung cell lines established from one patient during clinical follow up
66. Doxurubicin enhances complement susceptibility of human melanoma cells by extracellular oxygen radical formation
67. Effects of endogenous glutathione, superoxide dismutase, catalase, and glutathione peroxidase on adriamycin tolelarnce of Chinese hamster ovary cells
68. Role of glutathione and its associated enzymes in multidrug-resistant human myeloma cells
69. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells
70. Isolation of two Chinese hamster ovary cell mutants hypersensitive to topoisomease II inhibitors and cross-resistant to peroxides
71. Free radicals induced by adriamycin-sensitive and adriamycin-resistant cells: a spintrapping study
72. Peroxidative reactions in red cell biology
73. Copper- and Zinc- containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutthione peroxidase in normal and neoplastic human cell lines and normal human tissues
74. The effects of adriamycin (doxorubicin HCl0 on human red blood cells
75. The production of hydroxyl radicals by adriamycin in red blood cells
76. A relative deficiency of cytochrome P-450 and aryl hydrocarbon (benzo(a)pyrene) hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver
77. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat
78. Implications for therapy of drug-metabolizing enzymes in human colon cancer
79. Glutathione S-transferases and hepatocarcinogenesis
80. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines
81. Characterization of a human squamous cell line resistant to cis-diamminedichloroplatinum (II)
82. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors
83. Human placental form of glutathione-S-transferase (GST-π) as a new immunohistochemical marker for human colonic carninoma
84. Circumbention of deficient activation in mitomycin C-resistant human colonic carcinoma cells by the mitomycin C analogue BMY 25282
85. Resistance to alkylating agents: basic studies and therapeutic implications
86. Evidence for the generation of free radicals from certain quinone antitumor antibiotics upon reductive activation in solution
87. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics
88. DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells
89. DNA interstrand cross-link and free radical formation in a human multi-drug resitant cell line from mitomycin C and analogs
90. Cytocidal action of the quinone group and its relationship to antitumor activity
91. Characterization of L5178 murine lymphoblasts resistant to quinone antitumor agents